Aurobindo Shares Plummet: FDA Inspection Turns Negative
New Delhi — Aurobindo Pharma Limited experienced significant turbulence as its stock price dropped 8 percent to hit a 3-month low on February 10, 2026, following disappointing Q3 earnings and regulatory setbacks.

